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Synaptic glycine levels are controlled by GLYTs (glycine
transporters). GLYT1 is the main regulator of synaptic glycine
concentrations and catalyses Na+ –Cl− –glycine co-transport with
a 2:1:1 stoichiometry. In contrast, neuronal GLYT2 supplies
glycine to the presynaptic terminal with a 3:1:1 stoichiometry.
We subjected homology models of GLYT1 and GLYT2
to molecular dynamics simulations in the presence of Na+ . Using
molecular interaction potential maps and in silico mutagenesis,
we identified a conserved region in the GLYT2 external vestibule
likely to be involved in Na+ interactions. Replacement of Asp471
in this region reduced Na+ affinity and Na+ co-operativity of
transport, an effect not produced in the homologous position
(Asp295) in GLYT1. Unlike the GLYT1-Asp295 mutation, this
Asp471 mutant increased sodium leakage and non-stoichiometric
uncoupled ion movements through GLYT2, as determined by
simultaneously measuring current and [3H]glycine accumulation.
The homologous Asp471 and Asp295 positions exhibited distinct
cation-sensitive external accessibility, and they were involved in
Na+ and Li+ -induced conformational changes. Although these
two cations had opposite effects on GLYT1, they had comparable
effects on accessibility in GLYT2, explaining the inhibitory and
stimulatory responses to lithium exhibited by the two transporters.
On the basis of these findings, we propose a role for Asp471
in controlling cation access to GLYT2 Na+ sites, ion coupling
during transport and the subsequent conformational changes.
Key words: glycine, glycine transporter (GLYT), lithium,
neurotransmitter–sodium symporter, residue accessibility, sodium
coupling.
INTRODUCTION
Glycine is the main inhibitory neurotransmitter in the caudal
regions of the central nervous system and it exerts a positive
modulation of excitatory transmission acting as a co-agonist
of glutamate on NMDA (N-methyl-D-aspartate) receptors [1].
Synaptic glycine is cleared by the Na+ -driven Cl− -dependent
high-affinity plasma membrane transporters GLYT (glycine
transporter) 1 and GLYT2. GLYT1 is associated with both
the glycinergic and glutamatergic pathways, and it is the main
regulator of synaptic glycine levels [2]. In contrast, GLYT2
is located exclusively in glycinergic neurons and it supplies
glycine to the nerve terminal, providing the substrate to refill
synaptic vesicles via the low-affinity VIAAT (vesicular inhibitory
amino acid transporter) [1]. The distinct physiological roles of
the two glycine transporters are sustained by the higher sodium
coupling required for glycine transport via GLYT2 (three Na+ ),
as compared with GLYT1 (two Na+ ) [3,4]. Moreover, the two
transporters differ notably in the transient Na+ -dependent events
that occur in the absence of substrate (pre-steady-state kinetics),
thought to represent the initial stages of the transport cycle [4–6].
Gene-deletion studies demonstrated that whereas glycinergic
inhibition is enhanced by suppressing the GLYT1 gene, it is
attenuated by GLYT2 gene loss. Moreover, mutations in the
GLYT2 gene cause hyperekplexia in humans and congenital
muscular dystonia type 2 in calves [7]. These findings suggest
that selective modulation of GLYTs may improve defects
in glycinergic neurotransmission [2,8,9]. In addition, GLYT1
inhibitors may improve cognitive deficits in schizophrenia by
augmenting the glycine levels around NMDA receptors [9].
Accordingly, there is significant interest in developing specific
GLYT1 and GLYT2 pharmacology.
Glycine transporters belong to the NSS (neurotransmitter–
sodium symporter)/SLC (solute carrier) 6 family, together with
GABA (γ -aminobutyric acid) and monoamine transporters [10].
The three-dimensional structure of these transporters has been
revealed by homology with a prokaryotic homologue, LeuTAa
(leucine transporter from Aquifex aeolicus), the crystal structure
of which was resolved at 1.65Å (1Å = 0.1 nm) (PDB code 2A65),
providing a model for the eukaryotic transporters [11]. This
structure revealed a novel protein fold and provided a clear view
of the substrate-binding site and two Na+ -binding sites (Na1 and
Na2). The carboxy group of the substrate directly contacts the
Na+ ion at the Na1 site, providing a convincing explanation
for the ion–substrate coupling during co-transport. Moreover,
in eukaryotic transporters, a Cl− -binding site was identified in
close proximity to the Na1 site [12–14]. The residues forming
the external and cytoplasmic gates have been identified, and the
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overall structure has provided a robust framework to explain the
alternating access transport mechanism [15,16].
The LeuTAa model has also proved useful to analyse GLYT
structure and function. Missense mutations affecting residues
around the proposed glycine-binding site (W482R) and the Na1
site (N509S) inactivate GLYT2, and they cause hyperekplexia
in humans [7]. Furthermore, a serine residue in the GLYT2
substrate site prevents its interaction with the bulkier sarcosine
(N-methylglycine), whereas the smaller glycine residue at this po-
sition in GLYT1 (Gly305, equivalent to Ser481 in GLYT2) enables it
to use sarcosine as a substrate [17]. We recently demonstrated that
the co-ordinating residues in the Na1 and Na2 sites are conserved
in GLYTs [18], although the location of the third Na+ site in
GLYT2 is unknown. Using homology modelling and molecular
dynamics simulations of GLYTs in the presence of Na+ , we
identified Asp471 [in TM6 (transmembrane region 6)], within a
conserved region in the GLYT2 external vestibule, as a residue that
was likely to interact with Na+ . Mutations of Asp471 were analysed
biochemically and electrophysiologically, revealing differential
properties to the homologous GLYT1 position. Moreover, Na+ -
affinity, Na+ -co-operativity and Na+ –glycine coupling during co-
transport were altered in Asp471 mutants. Target cysteine residues
in GLYT2 and GLYT1 homologous positions exhibited sodium
and lithium-dependent accessibility and they mediated cation-
induced conformational changes, which paralleled the effects of
lithium on glycine transport [18]. Taken together, our findings
support a role for Asp471 in controlling cation access to GLYT2
Na+ sites, and in subsequent cation–substrate coupling.
EXPERIMENTAL
Computational methods
The crystallized leucine transporter from the bacterium A.
aeolicus (LeuTAa; PDB code 2A65) was used as the initial
template [11]. To obtain the best possible alignment, we built
a HMM (hidden Markov model) [19] with remote homologues
found using PSI-BLAST [20]. Initial models for GLYT1 and
GLYT2 with the bound substrate (glycine) were obtained using
MODELLER [18,21]. As the LeuTAa sequence was shorter than
those of GLYT1 and GLYT2, we used the ModLoop module
from the MODELLER program, which generates different models
for each loop. The lowest-energy model was selected in each
case. Some additional molecular dynamics simulation steps were
added, whereby the entire system was constrained and only the
loops were allowed to move in order to prevent possible steric
clashes during the loop generation step. Potential Na+ -binding
areas in the GLYTs were analysed in the models through the
molecular dynamics trajectories and MIP (molecular interaction
potential) maps. Simulations were prepared with the VMD
molecular visualization program [22] and simulated with the
NAMD 2.6 program [23], using the CHARMM force field. The
GLYT1 homology model was immersed in a rectangular box
of POPC (1-palmitoyl-2-oleoyl phosphatidylcholine) molecules
and solvated with explicit water molecules on both sides of the
membrane (12 Å layers). To simulate physiological conditions,
Na+ and Cl− ions were added at a concentration of 150 mM
NaCl, and they were guided by electrostatic potential calculations
(APBS program [24]). Next, a three-step protocol was used
to equilibrate the protein in its environment. This consisted of
a molecular mechanics minimization with initially fixed and
then constrained backbones, followed by a gradual temperature
increase up to 310 K and a final equilibration step at constant
temperature (310 K) in which the constraints were gradually
released. The total equilibration took 4 ns. Next, GLYT1 was
replaced with GLYT2 and both systems were again minimized,
heated, equilibrated and finally simulated for an additional
0.5 ns (GLYT2) or 1.0 ns (GLYT1). The structures from this
period were sampled for structural and energetic analyses at
regular intervals (up to 35), MIPs [van der Waals (Lennard-
Jones 12-6) and electrostatics (linear Poisson equation)] for
Na+ ions were calculated for each of the structures and the
Boltzmann average was determined. The mutants were built
using the Mutator plugin (version 1.0) implemented in VMD.
For each new structure generated, 20000 steps of molecular
mechanics energy minimization were performed with the same
force field as described above, and MIPS calculations were
performed using these optimized geometries. To locate the
position of the minimum value corresponding to the GLYT2
external vestibule, the 5000 MIP points with lowest energy
were saved and grouped into five clusters using the original
k-means algorithm [25], guided by the Euclidean distance
implemented in the Cluster 3.02 program. A representative point
(the minimal MIPs shown in Figure 1) was chosen on the basis
of the average co-ordinates and energies for all of the points within
the same cluster [26].
Generation and expression of GLYT mutants
Substitution mutants were generated by site-directed mutagenesis
with the QuikChange® site-directed mutagenesis kit (Stratagene),
using rat GLYT2 [27] and GLYT1 [28] (GenBank® accession
numbers L21672 and M88595 respectively) in pcDNA3 as
templates. Two independent Escherichia coli colonies carrying
the mutant plasmids were characterized by sequencing and
transport activity. The proteins were transiently expressed in
COS7 cells as described previously [29] using LipofectamineTM
Plus (Invitrogen) or NeofectinTM (Mid Atlantic Biolabs). For
mutants with reduced membrane expression, the total DNA was
increased to enhance glycine transport. Cells were incubated for
48 h at 37 ◦C prior to use.
Glycine transport assay
Transport assays in COS7 cells were performed at 37 ◦C in
0.25 ml of HBS [Hepes-buffered saline: 150 mM NaCl, 10 mM
Hepes/Tris (pH 7.4), 1 mM CaCl2, 5 mM KCl, 1 mM MgSO4
and 10 mM glucose] containing 2 μCi/ml 3H-labelled glycine
(1.6 TBq/mmol; PerkinElmer) and were isotopically diluted to
a final glycine concentration of 10 μM as described previously
[29], unless specified otherwise. Reactions were terminated after
10 min by aspiration followed by a brief rinse with HBS. Transport
was measured by subtracting the glycine accumulated in mock-
transfected COS7 cells from that of the transporter-transfected
cells and normalized to the protein concentration. In Na+ -
dependence experiments, NaCl was isotonically replaced by
choline chloride, LiCl or a combination of both, as indicated
in the Figure legends. Kinetic analyses were performed by varying
the glycine concentration in the uptake medium from 10 μM to
1000 μM.
Oocyte expression
The detailed experimental procedure can be found in [30]. The
desired cDNA was linearized with an appropriate enzyme and
cRNA synthesized and capped (Cap Analog and 200 units of
T7 RNA polymerase; Promega). Xenopus laevis frogs were
anaesthetized with MS222 (tricaine methanesulfonate, 0.10%),
their ovaries were removed and the animals were humanely killed.
The experiments were carried out in accordance with institutional
and national ethical guidelines. The oocytes were treated with
1 mg/ml collagenase (Type IA; Sigma) in Ca+ -free ND96 for
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at least 1 h at 18 ◦C. Healthy oocytes (stages V and VI) were
collected and injected with 12.5 ng of cRNA in 50 nl of water,
using a manual microinjection system (Drummond). The oocytes
were incubated at 18 ◦C for 3–4 days in MBS (modified Barth’s
saline) solution before electrophysiological studies.
Electrophysiology and data analysis
A classic two-electrode voltage-clamp set up (GeneClamp, Axon
Instruments; or Oocyte Clamp OC- 725B, Warner Instruments)
was used to record membrane currents under voltage-controlled
conditions at room temperature (22 ◦C). Reference electrodes
were connected to the experimental oocyte chamber via agar
bridges (3% agar in 3 M KCl). Borosilicate electrodes, with a tip
resistance of 0.5–2 M, were filled with 3 M KCl. The holding
potential (Vh) was maintained at − 40 mV, unless otherwise
stated. Voltage pulses to test potentials from − 140 to + 40 mV
in 20 mV increments were applied, and four pulses were averaged
at each potential to improve the signal-to-noise ratio. Signals were
filtered at 1 kHz and sampled at 2 kHz. Long-lasting recordings
were filtered at 20 Hz and sampled at 50 Hz. Data analysis was
performed using Clampfit 8.2 (Axon Instruments). All figures
were prepared with Origin 8.0 (Microcal Software). The external
control solution for oocytes contained 98 mM NaCl, 1.8 mM
CaCl2, 1 mM MgCl2 and 5 mM Hepes-free acid. Where indicated,
NaCl was replaced with equimolar TMA (tetramethylammonium)
chloride. The pH was adjusted to 7.6 by adding NaOH or TMA
hydroxide as appropriate.
Simultaneous measurement of glycine uptake and
glycine-induced currents
The ion/substrate stoichiometry of GLYTs was determined
by simultaneous measurement of glycine-induced inward
currents and [3H]glycine influx under voltage-clamp conditions
[31]. The membrane potential was clamped at − 40 mV
and after an initial baseline period in 98 mM Na+ buffer, oocytes
were superfused for 5 min with a buffer containing 100 μM
[3H]glycine (final specific activity of 1.1 MBq · mmol− 1). Oocytes
were perfused with ice-cold buffer, removed from the chamber,
washed and solubilized for liquid-scintillation counting. The
total substrate-evoked inward charge was obtained from the
time integral of the substrate-evoked current, converted into a
molar equivalent using the Faraday constant, and was related to
the amount of glycine uptake in the same oocyte. Non-specific
glycine uptake was determined using water-injected control
oocytes analysed under the same conditions and this parameter
was subtracted from the transport data from the cRNA-injected
oocytes.
Inhibition studies with the impermeant thiol reagents MTSET
{[2-(trimethylammonium)ethyl] MTS (methanethiosulfonate)
bromide} and MTSES [(2-sulfonatoethyl) MTS]
Before measuring transport, transfected COS7 cells grown on
polylysine-covered 24-well plates were washed with 1 ml of HBS
and then pre-incubated with 300 μl of medium containing the
indicated concentrations of MTSET or MTSES (Toronto Research
Chemicals) from a 100× stock solution in water (freshly prepared
for each experiment). Following a 10 min pre-incubation, the
medium was removed and the cells were washed once with
1 ml of the same solution and at least twice with 1 ml of
HBS (NaCl transport medium). All procedures were performed
at 22 ◦C unless indicated otherwise. After 5 min at 37 ◦C, the
cells were assayed for [3H]glycine transport as described above.
The transport detected was due to the activity of non-reactive
transporters [5].
Surface labelling with MTSEA (2-aminoethyl
methanethiosulfonate)–biotin and sulfo-NHS-SS-biotin
[sulfosuccinimidyl-2-(biotinamido)ethyl-1,3-dithiopropionate]
Thiol-specific biotinylation and total surface biotinylation was
performed with MTSEA–biotin (Toronto Research Chemicals)
and sulfo-NHS-SS-biotin (Pierce) on transfected COS7 cells
[29], using 0.5 mM MTSEA–biotin and a 3 h incubation with
streptavidin–agarose beads (Sigma). Proteins (reagent-reactive
transporters) were eluted from the beads with Laemmli buffer
[40 mM Tris/HCl (pH 6.8), 2% (w/v) SDS, 10% (v/v) glycerol,
0.1 M DTT (dithiothreitol) and 0.01% Bromophenol Blue]
for 10 min at 70 ◦C, and then analysed by Western blotting
(SDS/7.5% PAGE) with GLYT1- and GLYT2-specific antibodies
[32,33]. Protein bands were visualized by ECL (enhanced
chemiluminescence) and quantified on a GS-710 Calibrated
Imaging Densitometer (Bio-Rad Laboratories) using Quantity
One software and film exposures in the linear range. Calnexin
immunoreactivity was used as a loading control and S.E.M. values
were calculated from at least three separate experiments.
Data analysis
Non-linear regression fits of experimental transport data were
achieved with Origin. Results are means +− S.E.M. from
experiments that were repeated at least three times with equivalent
outcomes.
RESULTS
Molecular dynamics simulations of GLYT homology models and
characterization of selected mutants
Using molecular dynamics simulations of GLYT1 and GLYT2
models based on their structural homology with LeuTAa [11], we
identified a conserved region in the GLYT2 external vestibule
likely to interact with Na+ (Figures 1A–1D and Supplementary
Figure S1 at http://www.BiochemJ.org/bj/442/bj4420323add.
htm). In silico substitutions and calculated MIP maps for Na+
ions predicted a decrease in the minimum MIP energy when
residues shown in Figure 1(A) were replaced, which was most
apparent for Asp471, Asp542 and Asp635 (Figure 1E). High MIP
residues were mutated and the mutants expressed in COS7 cells
(Figures 2A and 2B). Although the majority of mutants reached
the plasma membrane [75–100% of wt (wild-type) membrane
expression; Figure 2A], only the most conservative substitution
at each position yielded active transporters (Figure 2B). When
active mutants were assayed for the sodium-dependence of
glycine transport, wt phenotypes were observed (Figures 2C
and 2D). An exception was Asp471. Mutation of this residue did
not produce functional rescue, even after the most conservative
substitution to glutamic acid, whereas its replacement by other
amino acids generated weakly active transporters (Figure 2B and
Table 1). Transport by Asp471 mutants did not reach saturation
by sodium at physiological NaCl concentrations (150 mM), and
the apparent affinity and co-operativity for Na+ were lower than
the wt (Figure 2E and Table 1). In contrast, substitution mutants
of the homologous aspartate residue in GLYT1 (Asp295 [34])
displayed sodium-dependence curves and kinetic parameters for
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Figure 1 GLYT2 external vestibule contains residues with high MIPs for sodium
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Figure 2 Mutagenesis and functional analysis of GLYT2 residues with high MIPs
COS7 cells expressing the wtGLYT2 or the indicated GLYT2 (A–C and E) or GLYT1 mutants (D and F) were subjected to NHS-SS-biotinylation and analysed by Western blotting (A), or were assayed
for glycine transport with 10 μM glycine in HBS containing 150 mM NaCl (B) or the indicated NaCl concentration by isotonic substitution of NaCl with choline chloride (C–F). *P < 0.05 with
respect to wtGLYT2 (ANOVA with Dunnett’s post-hoc test). (C) 100 % glycine transport (nmol of glycine/mg of protein per 10 min): GLYT2, 3.1 +− 0.4. Mutants: Y288F, 90 +− 8 %; F478Y, 92 +− 9 %;
D542E, 87 +− 8 % of wtGLYT2. (D) GLYT1, 5.2 +− 0.6. Mutants: Y127F, 10 +− 1 %; Y302F, 10 +− 1 %; H367A, 81 +− 7 % of wtGLYT1. (E) 100 % wtGLYT2 transport: 3.05 +− 0.5. Asp471 mutants: D471A,
0.98 +− 0.2; D471E, 0.47 +− 0.1. (F) 100 % GLYT1 transport: 5.2 +− 0.6. Asp295 mutants: D295A, 0.93 +− 0.1; D295E, 4.53 +− 0.4. Experimental data were fitted to the Hill equation.
Na+ similar to those of wtGLYT1 (EC50 and Hill coefficient;
Figure 2F and Table 1). Thus the sodium-dependence of glycine
transport was affected distinctly by mutation of homologous
GLYT aspartate residues, suggesting that the interaction between
Na+ ions and the transporter was selectively altered in GLYT2
[see functional features of Asp471 (GLYT2) and Asp295 (GLYT1)
mutants in Table 1] expected, the decrease in the apparent affinity
and co-operativity for Na+ was accompanied by reductions in
Vmax and increases in Km, revealing a crucial role of the aspartate
in glycine transport.
Electrophysiological characterization of Asp471 (GLYT2) and Asp295
(GLYT1) mutants
The electrophysiological parameters of transporters containing
alanine substitutions of the homologous aspartate residues were
(A and B) Lateral view of the modelled GLYT2 (A) and GLYT1 (B) structures showing the isosurfaces corresponding to favourable interactions with Na+ ions ( − 5 kcal/mol, red). The region
containing residues with high MIPs for Na+ ions in GLYT2 is magnified to compare it with the equivalent area of GLYT1. (C and D) External view of the GLYT external vestibule showing the positions
of Asp471 in GLYT2 (C) and Asp295 in GLYT1 (D) relative to the Na1 and Na2 sites. Na+ ions are represented as small green spheres. In (C), the location of the Na+ ion corresponds to the minimum
MIP found in the area (yellow sphere; see the Experimental section). The protein is shown in green and the main residues as sticks coloured by atom type (green, blue, and red for carbon, nitrogen
and oxygen atoms respectively). Hydrogen atoms have been omitted for clarity. Broken black lines in (C) denote residues in close contact with Na+ ions. (E) Representation of the MIP surface (in
red and contoured at − 5 kcal/mol) located at the external vestibule area of wtGLYT2 and different in silico mutants. The position of the minimum MIP found in this area is highlighted by a small
yellow sphere. The GLYT2 structure is represented in green. The energy corresponding to each minimum MIP is also shown.
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Table 1 Kinetic parameters of glycine transport by Asp471 (GLYT2) and Asp295 (GLYT1) mutants
Experimental conditions were as in Figures 2(C)–2(F). Values are means +− S.E.M. for experiments performed in triplicate at 10 μM glycine and 150 mM NaCl. > or < indicates that transport was
not saturated at the maximum concentration assayed. NH, non-hyperbolic.
Transporter V max (nmol/mg per 10 min) K m (μM) EC50 (mM) (Na+ )* h (Hill coefficient) (Na+ )*
wt GLYT2 52 +− 2.5 143 +− 25 66 +− 14 2.8 +− 0.2
GLYT1 93 +− 8.7 136 +− 19 71 +− 8.2 2.0 +− 0.4
D471 (GLYT2) D471E 10 +− 2.7 288 +− 23 >150 <2.0
D471A 23 +− 1.4 200 +− 34 >150 <2.0
D471C 12 +− 1.5 194 +− 16 86 +− 9.3 2.0 +− 0.4
D471G NH >1000 >150 <2.0
D471K 25 +− 8.0 572 +− 45 66 +− 2.4 2.0 +− 0.3
D295 (GLYT1) D295E 87 +− 9.0 203 +− 21 75 +− 6.2 2.0 +− 0.4
D295A 32 +− 3.1 267 +− 26 82 +− 11 1.9 +− 0.5
D295C 15 +− 1.2 195 +− 19 88 +− 10 2.0 +− 0.4
D295G 20 +− 2.8 272 +− 25 95 +− 9.2 1.9 +− 0.6
D295K 25 +− 3.3 317 +− 29 80 +− 6.8 1.9 +− 0.4
*Choline chloride substitution.
tested in Xenopus laevis oocytes. Currents induced by 1 mM
glycine at different sodium concentrations were recorded at
− 40 mV from four representative oocytes (Figure 3A, GLYT2,
and Figure 3B, GLYT1). As reported previously [5], wtGLYT2
displayed leak currents, a constitutive transport-independent
conductance that is only detected in the absence of substrate,
calculated by subtracting the current measured in the presence
of permeating ions from that measured in the presence of non-
permeating ions, in this case TMA. These currents were sodium-
dependent and were larger in the D471A mutant than in wtGLYT2,
and they were never visualized in GLYT1 (GLYT2 currents in the
absence of glycine under a voltage-step protocol are shown in
Figure 3C). The current from the GLYT2 mutant increased with
negative voltage and increasing sodium concentration, and thus
it was visibly larger than that of wtGLYT2 at the highest Na+
concentration used (98 mM). This behaviour is compatible with
increased sodium leakage of the GLYT2 mutant.
The mutation of the homologous aspartate residues had
opposing effects in the two transporters in terms of the transport-
associated currents (substrate-induced currents). GLYT2D471A
transport currents were larger than in the wt (Figure 3A),
whereas transport currents in the GLYT1 mutant were lower
(approximately 60%; Figure 3B) than in the wt. These
opposing effects were clearly detected after application of
the aforementioned voltage-step protocol and plotting the net
glycine-elicited currents (ITr_Gly = INa_Gly − INa) against the voltage
(Figure 4). GLYT2 mutant currents increased with negative
voltage and increasing sodium concentration (Figure 4A), and
trended to display a current reversal, whereas no such behaviour
was evident with the GLYT1 mutant currents (Figure 4B).
Although the small transport currents observed in GLYT1
mutants were consistent with the decreased [3H]glycine transport
displayed by these mutants in COS7 cells (Table 1 and Figure 2B),
the large currents detected in the D471A mutant were unexpected.
Thus we analysed radioactive glycine flux in oocytes, confirming
that both GLYT2 and GLYT1 mutants showed similar levels of
[3H]glycine transport as those of the wt controls (Figures 5A and
5B). The discrepancy observed between currents and radioactive
substrate transport in the GLYT2 mutant suggested the presence
of a current in excess of that associated with the stoichiometric
charge translocation [35], such that the mutation increased non-
stoichiometric or uncoupled ion movements mediated by GLYT2.
To confirm this hypothesis, we determined the charge/glycine
flux ratios by simultaneously measuring current and [3H]glycine
accumulation in the same oocyte (Figure 5C). GLYT2 moves two
positive charges per transported glycine molecule [4], and our
measurements revealed a value of 2.3 +− 0.7 (n = 4), increasing
to 11.0 +− 1.5 (n = 5) in the D471A mutant, significantly greater
than the wtGLYT2 value. In contrast, the charge/flux coupling
ratios for wtGLYT1 and the D295A mutant were 1.2 +− 0.3(n = 4) and 1.7 +− 0.2 (n = 4) respectively. These data confirm the
distinct consequences of aspartate mutation in the two glycine
transporters, demonstrating the disrupted coupling between Na+
and glycine transmembrane flux induced by the D471A mutation
in GLYT2.
Asp471 mutation (GLYT2) alters the transporter response
to lithium ions
We previously reported that wtGLYTs respond differentially to the
presence of lithium, which stimulates Na+ -driven transport via
GLYT2, but inhibits it via GLYT1 [18,36,37]. We investigated
whether the effect of lithium on the GLYTs was altered by
mutation of the homologous aspartate residues. The physiological
NaCl concentration of 150 mM was reduced to 50 mM upon
addition of 100 mM choline chloride or LiCl (Figure 6A). As
expected, replacement of Na+ with choline (which does not
interact with the transporters) reduced glycine transport, slightly
more affecting transport to GLYT2 and D471A, which are more
dependent on sodium (remaining transport activity 71–74% at
150 mM NaCl, closed bars), than GLYT1 transporters (86–87%,
closed bars). In contrast, partial substitution of sodium by lithium
revealed the different responses of wt transporters, where GLYT2
was stimulated, whereas GLYT1 was inhibited as compared with
choline substitution. Interestingly, although the GLYT1D295A
mutant displayed a wt-like response, being inhibited by lithium,
the GLYT2D471A mutant was not stimulated by lithium, in direct
contrast with its corresponding wt. This change in the lithium
response of the GLYT2D471A mutant was more evident when the
Vmax of glycine transport was measured in the two previous ionic
conditions (Figures 6B and 6C). All GLYT1 and GLYT2 aspartate
mutants exhibited similar responses to their corresponding wt
controls, except for the GLYT2D471A mutant (Figure 6B). The
absence of an altered response to lithium in the GLYT2D471E
mutant suggests that this change is due to Asp471 neutralization.
Given that the differential lithium responses are mediated by
lithium binding to the Na2 sites of GLYTs [18], our results
c© The Authors Journal compilation c© 2012 Biochemical Society
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Figure 3 Electrophysiological characterization of the GLYT2D471A and GLYT1D295A mutants
(A and B) Inward currents recorded at a holding potential of − 40 mV elicited by application of 1 mM glycine at the indicated sodium concentrations in four representative oocytes expressing
wtGLYT2 or GLYT2D471A (in A), and wtGLYT1 or GLYT1D295A (in B). The zero current level (the current in the presence of 98 mM TMA, ITMA) is shown by the long horizontal line.
(C) Current–voltage relationship of leak currents in wtGLYT2 and GLYT2D471A. From a holding potential of − 40 mV, pulses of 20 mV and 400 ms ranging from − 140 mV to + 20 mV were
applied to oocytes expressing the protein. The steady-state currents measured at each potential were plotted after subtracting the traces recorded in 98 mM TMA chloride from traces recorded in the
presence of the indicated sodium concentration. Data were collected in the presence of the indicated sodium concentration and in the absence of glycine.
suggest that Asp471 neutralization interferes with cation access
to the GLYT2 Na2 site.
Accessibility to MTS reagents of cysteine residues introduced at
positions 471 (GLYT2) and 295 (GLYT1)
The control of cation access may be modulated by positions
sensitive to the presence of cations. We introduced cysteine
residues into the homologous GLYT2 and GLYT1 target positions
under study and tested their external accessibility to impermeant
MTS derivatives, specific thiol reagents, subsequently analysing
transporter activity and surface labelling [38] (the strategy used
for these experiments is illustrated in Supplementary Figure S2 at
http://www.BiochemJ.org/bj/442/bj4420323add.htm). Although
a D471C mutant was used for GLYT2, which is resistant to
MTS reagents, the MTS-resistant GLYT1C62A mutant was
used to define the GLYT1 background [5,39,40]. The cysteine
residues introduced at the target positions were externally
accessible in both transporters and bound all of the MTS reagents
assayed, including the positively charged MTSET, the negatively
charged MTSES and a biotin-coupled MTS derivative (MTSEA–
biotin). Non-cysteine amino acid substitutions at the target
positions yielded MTS-resistant transporters such as wtGLYT2 or
GLYT1C62A, demonstrating that the cysteine residues introduced
were indeed reactive (Supplementary Figure S2B).
Transport activity of the two cysteine mutants was inhibited
by MTS reaction (Figure 7), although cations produced opposite
effects in GLYT2 (Figure 7A) and GLYT1 (Figure 7B; attenuation
of inhibition in the GLYT2 mutant and increased inhibition,
especially by Na+ , in the GLYT1 mutant). These opposing effects
were more evident when analysing MTSES inhibition, suggesting
better reagent access due to its negative charge and slightly
smaller size (Figures 7C and 7D) [41]. This was confirmed by the
greater decrease in MTSEA–biotin binding seen following pre-
incubation with MTSES rather than MTSET in HBS (Figure 7F),
despite using equally reactive concentrations of each reagent
[38]. This experiment also confirms that all three reagents bind
to the same exogenous cysteine residue. The protection offered
by cations against the inhibition of GLYT2D471C transport was
maintained at low temperatures (incubation with the reagent at
4 ◦C; Figure 7E), suggesting that only minor conformational
changes are required to induce protection, or that sodium binding
and D471C protection occur at sites in close proximity. These
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Figure 4 Current–voltage plots of net transport currents
(ITr_Gly = INa_Gly − INa) of the GLYT2D471A and GLYT1D295A mutants
Net transport currents: the same protocol as in Figure 3(C) was applied to oocytes expressing
the transporter indicated. At each sodium concentration, the steady-state currents measured
in the presence of 1 mM glycine at each potential were plotted after subtracting traces recorded
with the same concentration of NaCl alone. (B) Calculation of GLYT1 K 0.5NaItr for sodium at each
voltage assayed indicated a lower Na+ affinity for the mutant at potentials more positive than
− 60 mV. (A) In the GLYT2 mutant, Na+ affinity was lower than that of the wt at potentials more
positive than − 100 mV.
findings may be compatible with the location of Asp471 close to
an Na+ -interaction site.
When we analysed the binding of MTSEA–biotin, which
measures the actual accessibility of the target positions (and
not the resulting transport), we found differences between the
GLYT2 and GLYT1 cysteine mutants (Figure 8). In accordance
with the cation effects on transport inhibition by the MTS, a
small protective effect of MTSEA–biotin binding was detected
at low Na+ concentrations (0–50 mM) in the GLYT2 mutant,
suggesting that protection of transport is achieved by preventing
MTS binding to a position 471 conformation acquired upon
high-affinity binding of Na+ (Figures 7A, 7C, 7E and 8A).
This may represent a transient conformation [16]. In contrast,
Na+ increased MTSEA–biotin binding in the GLYT1 mutant,
in agreement with the potentiating effect of sodium on transport
inhibition (Figures 7B, 7D and 8A). The accessibility of the target
positions was also lithium-sensitive (Figures 8C and 8D) and
the dose-responses to lithium and sodium revealed an interesting
aspect: after the protection elicited at low concentrations, both
cations exposed position 471 of GLYT2, probably via cation-
driven conformational changes. This suggests that both Na+
and Li+ induce a common transport-competent conformation
in GLYT2. However, GLYT1C295 was exposed by Na+ but
occluded by Li+ , suggesting that lithium may induce an inhibitory
conformation, consistent with the inhibitory effect of Li+ on this
transporter. Moreover, these effects were temperature-sensitive,
as was the case for cation-induced conformational changes
(Figures 8E and 8F). Thus positions GLYT2471 and GLYT1295
are conformationally active in addition to displaying cation
sensitivity.
Figure 5 Glycine transport and ion–substrate coupling of the GLYT2D471A
and GLYT1D295A mutants in oocytes
(A and B) Control oocytes or oocytes expressing the indicated transporters were assayed for
[3H]glycine transport (100 μM final concentration, specific activity 1.1 MBq · mmol− 1) over
5 min in external control solution containing the indicated NaCl concentration isotonically
replaced by TMA chloride (n = 5 per condition). The concentration of glycine (pmol)
accumulated in control oocytes was subtracted from that of cRNA-expressing oocytes and
the result was plotted against the concentration of sodium present in the assay. (C) Current
was continuously monitored in a single oocyte expressing the indicated transporters clamped
at a holding potential of − 40 mV. A stable baseline current was established in 98 mM
NaCl before superfusing 100 μM [3H]glycine for 5 min and washing out with the same buffer
without the tracer. The induced current was monitored during the incubation period and the
total accumulated glycine was subsequently quantified. The total current was converted into
charge and the net charge movement per translocated glycine molecule was plotted. *P < 0.05;
**P < 0.01; ***P < 0.001 with respect to wt (two-tailed Student’s t test).
DISCUSSION
Since the elucidation of the three dimensional structure of
LeuTAa [11], homology models have represented valuable tools
to study the structure of the SLC6 transporters, revealing that
family members show similar, but not identical, structures
to the prokaryotic homologue template [10,15,42]. Glycine
transporters share 50% sequence identity, but exhibit differing
sodium/substrate stoichiometry, an interesting feature that may
contribute to the singularity of their structures. We recently
generated GLYT1 and GLYT2 homology models that predicted
the conservation of the two sodium sites (Na1 and Na2) present
in the template, and we confirmed their validity by mutagenesis
and functional analysis [18]. To identify the additional sodium
coupling ion in GLYT2, the models were subjected to molecular
dynamics simulations in the presence of Na+ . Calculated MIP
maps and in silico mutagenesis revealed a conserved region in
the GLYT2 external vestibule that displayed a high probability
of interacting with Na+ . Three aspartate residues within this
region (Asp471, Asp542 and Asp635) exhibited the highest MIP
for Na+ ions, and these values were reduced strongly by in
silico substitutions. Mutagenesis analysis demonstrated that all
three of these residues were crucial for glycine transport. All
Asp635 substitution mutants were inactive, in accordance with its
proposed role in the transporter external gate [11]. Similarly, all
Asp542 mutants were inactive, with the exception of the most
conservative substitution, which exhibited a functional wt-like
phenotype. Asp471 mutations were partially tolerated, and, despite
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Figure 6 Effect of lithium on glycine transport by the GLYT1 and GLYT2
mutants
COS7 cells expressing the indicated transporters were assayed for 3[H]glycine transport (10 μM,
final glycine concentration) in HBS containing 150 mM NaCl (no substitution, 100 % of
transport in A), 50 mM NaCl + 100 mM choline chloride (NaCl/ChCl, closed bars) or 50 mM
NaCl + 100 mM LiCl (NaCl/LiCl, open bars; A–C). (A) The transport activity obtained by
isotonically substituting two-thirds of the NaCl concentration (100 mM) with either ChCl or
LiCl is expressed as a percentage of transport at 150 mM NaCl. The 100 % glycine transport
values in nmol of glycine/mg of protein per 10 min were as follows: GLYT2, 3.4 +− 0.3; D471A,
0.96 +− 0.2; GLYT1, 5.3 +− 0.5; D295A, 0.92 +− 0.1. (B and C) V max values for glycine transport
induced by NaCl/ChCl or NaCl/LiCl in wtGLYT2 and Asp471 mutants (B), and in wtGLYT1 and
Asp295 mutants (C). *P < 0.05; **P < 0.01 with respect to choline substitution (Student’s t
test).
the fact that this feature may suggest that the residue is dispensable
for transport, functional analysis revealed reduced affinity and
apparent co-operativity for Na+ as measured by radiotracer flux
assays, in comparison with the homologous (Asp295) mutation in
GLYT1. We therefore undertook the study of the functional role
of Asp471.
Electrophysiological characterization of the D471A mutant
revealed an enhanced constitutive transport-independent
conductance in the absence of substrate, consistent with the Na+
leak current reported previously in wtGLYT2 [4]. This behaviour
was not observed for the corresponding GLYT1 mutation. The
leakage current increased with negative voltage and increasing
sodium concentration, and it was reversed in the GLYT2 mutant
at high sodium concentrations. Although the results suggest
that the leak current is carried by Na+ ions, this hypothesis
remains to be confirmed. Mutation of homologous aspartate
residues in GLYTs produced opposing effects on transport-
associated currents: a reduction for GLYT1 and an increase for
GLYT2. Simultaneous measurement of current and [3H]glycine
accumulation in the same oocyte revealed that the Asp471 mutation
increased non-stoichiometric or uncoupled ion movements carried
by GLYT2, indicative of defective ion coupling in this mutant.
This observation suggests this aspartate residue is involved in
coupling Na+ and glycine fluxes in GLYT2, but not in GLYT1.
The increased leakage and uncoupling of the D471A mutant is
compatible with the mechanism proposed to generate uncoupled
currents in SERT (serotonin transporter) by modulating the
relative distances and orientation of TM1–TM6 residues [43],
and with the coupling of Cl− binding to transport [14,44].
However, it remains unknown whether the substrate-dependent
Figure 7 Effect of cations on MTSET and MTSES sensitivity in mutants with
target cysteine residues in GLYT2-Asp471 and GLYT1-Asp295
COS7 cells expressing D471C (A and C) or D295C/C62A (B and D) were treated at 22◦C
with 0.2 mM MTSET (A and B) or with 0. 6 mM MTSES (C and D) in HBS containing the
indicated cation (Na+ or Li+ ) concentrations (choline chloride substitution). After a 10 min
incubation, the cells were washed and glycine transport was determined in NaCl-containing
HBS. MTS inhibition of glycine transport is expressed as the fraction of the uptake inhibited
[100 − (100×uptake after MTS/uptake before MTS)]. The 100 % transport values (nmol of
glycine/mg of protein per 10 min) were 0.92 +− 0.3 (D471C) and 0.59 +− 0.1 (D295C/C62A). (E)
Experimental conditions as in (A) but where cells expressing D471C were treated at 22◦C with
0.5 mM MTSES and at 4◦C with 1 mM MTSES in HBS containing the indicated concentrations
of Na+ , and were assayed for transport at 10 μM glycine in NaCl/HBS. The effect of MTSES on
uptake is expressed as in (C). *P < 0.05; **P < 0.01 with respect to 0 mM cation (Student’s t
test). (F) MTSEA–biotin labelling after a 10 min pre-incubation with HBS (containing no MTS
reagent), 1 mM MTSET or 10 mM MTSES. After pre-incubation, the cells were processed as
described in the Experimental section.
and -independent currents share a common pathway and/or
molecular contacts as they permeate the transporter. Since both
processes are affected by a point mutation, they may share a
common pathway. The observed effects of lithium on aspartate
mutants also support this hypothesis: neutralization of Asp471
altered the effect of lithium on GLYT2 transport, resulting in
inhibition rather than stimulation of the mutant by the cation,
whereas the D295A mutant exhibited the same inhibitory response
to lithium as its corresponding wt control. A similar phenotypic
change is produced upon mutation of residues associated with the
Na2 site of GLYT2 [18], further reinforcing the link between
Asp471 and the Na2 site, and suggesting that neutralization
of Asp471 interferes with the access of cations to the GLYT2 Na2
site. Alteration of the proper allosteric connection between Na1
(Na+ -bound) and Na2 (Li+ -bound) sites, which is required for the
stimulatory effect of lithium at GLYT2, could explain the mutant’s
behaviour. Alternatively, the decreased affinity for sodium in the
mutant may result in similar Na+ and Li+ affinities, thereby
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Figure 8 Cation-dependence of MTSEA–biotin accessibility in mutants with target cysteine residues at GLYT2-Asp471 and GLYT1-Asp295
COS7 cells expressing D471C (A and C) or D295C/C62A (B and D) were treated at 22◦C with 0.5 mM MTSEA–biotin in HBS containing the indicated concentrations of Na+ (A and B) or Li+ (C
and D; choline chloride substitution), then washed, and streptavidin-bound proteins were detected by immunoblotting (60 or 4 μg of biotinylated or non-biotinylated proteins were loaded per lane
respectively). CNX, calnexin loading control. Upper panels in (A–D): representative Western blots. Lower panels in (A–D): densitometric analysis of the average values of three or four independent
Western blots. (E and F) Cells expressing D471C were labelled at 22◦C or 4◦C with 0.5 mM MTSEA–biotin in HBS with the indicated Na+ concentrations, then washed, and streptavidin-bound
proteins were detected in immunoblots (60 or 4 μg of biotinylated or non-biotinylated proteins were loaded per lane respectively). *P < 0.05 with respect to 0 mM cation (Student’s t test).
reducing the selectivity for Na+ [45]. The similar magnitude of
protection of D471C MTS inhibition by Na+ and Li+ suggests a
comparable affinity for the two cations. The most conservative
mutation of Asp471 to glutamic acid, although reducing the
Na+ affinity, did not alter the Li+ response when compared
with wtGLYT2, suggesting a less dramatic alteration of cation
selectivity or of the conformational connections between Na+
sites.
MTS accessibility suggests a role for Asp471 in maintaining a
conformational connection with the Na2 site, probably mediating
the conformational changes necessary for translocation to occur.
MTSES inhibition and protection by Na+ of D471C was easier
than that of MTSET, probably due to the greater accessibility of
a negatively charged reagent in the presence of bound sodium.
MTSEA–biotin displacement by MTSES, and the persistence
of Na+ protection at 4 ◦C, suggests that MTSES binding is
prevented by the direct physical occlusion by Na+ of the
target cysteine residue. However, sodium protection of binding
of the bulkier MTSEA–biotin to D471C was lost at 4 ◦C,
indicating that cation binding induces conformational changes
that occlude Cys471. This finding demonstrates that position 471
is conformationally active, as well as cation-sensitive. Moreover,
this appears not to be exclusive to the 471 (GLYT2) position,
as accessibility of the homologous 295 (GLYT1) position to
MTS compounds was also modified by the presence of Na+ and
Li+ , with differing consequences for each transporter. Although
saturating concentrations of Na+ and Li+ exposed position
471 (GLYT2), probably inducing a common transport-competent
conformation, position 295 (GLYT1) was exposed by Na+ but
occluded by Li+ , suggesting that the latter induces a transport-
inhibitory conformation. This interpretation is in agreement with
previous reports implicating several SLC6 external vestibule
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residues in conformational changes following lithium binding
[36,37,46].
In summary, Asp471 in GLYT2 is a key residue selected
after molecular dynamics simulations and subsequent in silico
mutagenesis on the basis of high MIP maps, which were consistent
with a highly probable and well localized Na+ -like binding site
(Figure 1). Na+ -binding energy values were sufficiently stable to
accommodate the ion in an adequate environment [47]. Similar
results have been reported for glutamate [48] and leucine [49]
transporters, suggesting that a pre-formed cavity exists in the
initial model, and, as simulation progresses, the protein itself
conforms a favourable environment for Na+ . We found that Asp471
plays a key role in Na+ affinity and Na+ –glycine coupling during
co-transport. Moreover, Asp471 mutation induced Na+ leakage and
affected Na+ selectivity with respect to Li+ . Asp471 is a cation-
sensitive and conformationally active residue involved in Na+ -
and Li+ -induced conformational changes. We propose a role for
Asp471 in controlling cation access to GLYT2 Na+ sites, as well
as ion coupling and the induction of subsequent conformational
changes. Some of these features may be compatible with the
expected properties of the Na3 site, including its proximity to
the external gate of the transporter. However, the affinity values
of approximately − 5 kcal/mol (1 kcal = 4.184 kJ) resulting
from our computational studies are indicative of low-affinity
sites that can interchange ions (as Li+ or K+ ) with the bulk
solvent [48,49]. Moreover, as the sodium leakage and uncoupling
that occurs in Asp471 mutants prevents the measurement of
Na+ –glycine stoichiometry, further studies will be required to
determine whether this is a true Na+ site or merely a modulatory
site.
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Figure S1 Sequence alignment of the regions including the residues
studied within related rat SLC6 transporters and LeuTAa
Sequence similarity with rat GLYT2a of the regions containing Tyr221 (TM1), Tyr288 (TM3),
Asp471, Phe478 (TM6), Asp635 (TM10) and Asp542 [EL4 (extracellular loop 4)] from the indicated
members of the SLC6 family. Residues relevant to the present study are indicated with arrows.
Identical residues in the relevant positions are shown in red.
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Cation access control in GLYT2
Figure S2 External accessibility of cysteine residues introduced at positions 471 (GLYT2) and 295 (GLYT1)
COS7 cells expressing the indicated transporters were treated at 22◦C with the specified MTSET concentrations in choline chloride in HBS, then washed, and glycine transport was determined in
NaCl HBS. (A) Experimental data were fitted to a first-order exponential decay curve. 100 % glycine transport was in nmol of glycine/mg of protein per 10 min: (A) 5.0 +− 0.5, 4.3 +− 0.2, 3.2 +− 0.2,
0.71 +− 0.3, 0.62 +− 0.1 for wtGLYT1, C62A, wtGLYT2, D471A and D295A/C62A respectively and (B) 3.0 +− 0.3, 4.5 +− 0.1, 0.75 +− 0.3, 0.64 +− 0.2, 0.70 +− 0.1, 0.59 +− 0.1, 0.68 +− 0.2, 0.60 +− 0.2
for wtGLYT2, C62A, D471A, D295A/C62A, D471G, D295G./C62A, D471C and D295C/C62A respectively. MTSET inhibition is expressed as the fraction of uptake inhibited [100 − (100×uptake
after/uptake before)]. *P < 0.05 relative to background transporter (ANOVA with Dunnett’s post-hoc test).
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